143 related articles for article (PubMed ID: 10648124)
1. Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression.
Tsuruma T; Yagihashi A; Hirata K; Torigoe T; Araya J; Watanabe N; Sato N
Cell Immunol; 1999 Dec; 198(2):103-10. PubMed ID: 10648124
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.
Kundu N; Fulton AM
Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639
[TBL] [Abstract][Full Text] [Related]
4. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
5. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
6. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
Kraus E; Lambracht D; Wonigeit K; Hünig T
Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
[TBL] [Abstract][Full Text] [Related]
8. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
10. [Expression of recombinant mouse IL-1beta significantly down-regulates NK cell mediated cytolysis [corrected] against H22 hepatoma cells].
Xiao WL; Liang SJ; Mu DZ; Wang XJ; Wu HN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1130-2. PubMed ID: 18062884
[TBL] [Abstract][Full Text] [Related]
11. Natural killer target molecules associated with the transformation of the oncogene-transfected fibroblast.
Cho JM; Sato N; Yagihashi A; Konno A; Hara I; Konn S; Torigoe T; Qi W; Takashima T; Takahashi N
Cancer Res; 1991 Aug; 51(16):4250-6. PubMed ID: 1868445
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
14. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
Talmadge JE; Phillips H; Schindler J; Tribble H; Pennington R
Cancer Res; 1987 Nov; 47(21):5725-32. PubMed ID: 3499218
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
[TBL] [Abstract][Full Text] [Related]
16. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
[TBL] [Abstract][Full Text] [Related]
17. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
18. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity.
Chadwick BS; Miller RG
J Immunol; 1992 Apr; 148(7):2307-13. PubMed ID: 1545133
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.
Handgretinger R; Kimmig A; Lang P; Daurer B; Kuci S; Bruchelt G; Treuner J; Niethammer D
Nat Immun Cell Growth Regul; 1989; 8(4):189-96. PubMed ID: 2507905
[TBL] [Abstract][Full Text] [Related]
20. Involvement of peptide antigens in the cytotoxicity between 70-kDa heat shock cognate protein-like molecule and CD3+, CD4-, CD8-, TCR-alpha beta- killer T cells.
Takashima S; Sato N; Kishi A; Tamura Y; Hirai I; Torigoe T; Yagihashi A; Takahashi S; Sagae S; Kudo R; Kikuchi K
J Immunol; 1996 Oct; 157(8):3391-5. PubMed ID: 8871636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
